Investors & Media
Medical Affairs
Contact

Investors & Media

At Vera Therapeutics, our mission is to pursue truth in science to transform medicine in autoimmune diseases, starting with kidney disease.

Stock Information

Minimum 15 minutes delayed. Source: LSEG

View more

Corporate Presentation

Download

Latest Press Releases

Nov 5, 2026

Vera Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results

Nov 2, 2026

Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Oct 22, 2026

Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of Medicine

Events & Presentations

Nov 10, 2026 11:30 AM EST

Guggenheim 3rd Annual Healthcare Innovation Conference

Nov 5, 2026 4:30 PM EST

Third Quarter 2026 Financial Results Investor Webcast

Oct 22, 2026 4:30 PM EDT

Virtual Investor Event: ASN Kidney Week 2026

Contact

INVESTOR INQUIRIES

IR@veratx.com

MEDIA INQUIRIES

corporatecommunications@veratx.com

Leaving this site

The link will take you to a third-party site and is not owned or controlled by Vera. Vera makes no representation as to the accuracy of the information contained on third-party sites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.